METHOD OF TREATING OR PREVENTING CENTRAL NERVOUS SYSTEM DISORDERS WITH COMPOUNDS HAVING SELECTIVITY FOR THE ALPHA 3 SUBUNIT OF THE BENZODIAZEPINE RECEPTOR

摘要

The present invention relates to the use of 1-ar(alk)ylimidazolin-2-ones which contain a disubstituted amine radical in the 4-position for the treatment or prevention of central nervous system disorders including depression, anxiety, movement disorders, and especially dystonia, and psychotic disorders, and especially schizophrenia and psychotic symptoms associated to other mental disorders.